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Abstract
Background: There is a lack of data on the long-term outcome of total hip arthroplasty procedures, as assessed by
validated tools.
Methods: We conducted a follow-up study to evaluate the quality of life and functionality of 250 patients an
average of 16 years (range: 11-23 years) after total hip arthroplasty using a validated assessment set including the
SF-36 questionnaire, Harris Hip Score, WOMAC score, Functional Comorbidity Index, and a study specific
questionnaire. Models of multiple stepwise linear and logistic regression analysis were constructed to evaluate the
relationships between several explanatory variables and these functional outcomes.
Results: The SF-36 physical indexes of these patients compared negatively with the normative values but positively
with the results obtained in untreated subjects with severe hip osteoarthritis. Similar results were detected for the
Harris Hip Score and WOMAC score. There was a 96% rate of post-surgical satisfaction. Hip functionality and
comorbidities were the most important determinants of physical measures on the SF-36.
Conclusions: Patients who had undergone total hip arthroplasty have impaired long-term self-reported physical
quality of life and hip functionality but they still perform physically better than untreated patients with advanced
hip osteoarthritis. However, the level of post-surgical satisfaction is high.
Background
Hip osteoarthritis (OA) is a cause of severe pain and
disability [1] but can be successfully treated with total
hip arthroplasty (THA). Short- and medium-term THA
studies report substantial improvements in the generic
health-related quality of life (HRQoL) [2-6] and hip
functionality [4,7] in subjects with OA. Currently about
20% of THA are performed in people younger than 60
years with variable diagnoses [8]; the general increase in
life expectancy is expected to further increase the need
for this procedure [9]. These data suggest that greater
attention should be paid to the long-term follow-up
results of hip replacement surgery. A comprehensive
approach requires the combined use of generic and dis-
ease-specific patient-oriented validated measures [5], but
there is a lack of data on the long-term outcome of
THA procedures, as assessed by these validated tools.
Even less is known about possible predictors of long
term outcomes of these procedures. The goals of the
present study were: 1) to evaluate by validated instru-
ments whether subjects who had undergone THA more
than 11 years earlier had severe functional impairment
and/or disability, and 2) to identify possible outcome
predictors of long term HRQoL and hip functionality
after THA.
Methods
After approval by the local ethics committee, we
enrolled patients who had undergone THA at our insti-
tution from 1985 to 1996 who fulfilled the following
inclusion criteria: (1) age less than 70 years at operation
(2) total hip arthroplasty, and (3) primary surgery. On
the basis of these criteria we selected 412 subjects. One-
hundred sixteen (28%) of them had died before our
study commenced. Thus, 296 were available for follow-
up examination. We were able to collect data on 250
patients (162 females and 88 males) with 330 THA (80
bilateral procedures), who represented 84% of the sur-
viving patients. Forty-six subjects refused to participate
in the study because of severe comorbidities or lack of
interest. The selection of patients is shown in Figure 1.
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cipants and those subjects lost to follow-up with respect
to gender (p = 0.83), preoperative diagnosis (p = 0.37),
operating surgeon (p = 0.34), or use of cemented/
cementless implant (p = 0.55). The only parameter that
differentiated between the two groups was the mean
age, which was significantly older in the subjects lost to
follow-up (76.8 vs 70.8 years; p = 0.004). The patients’
data are shown in Table 1. A direct transgluteal lateral
approach was used in all cases. Out of 330 implants,
118 (36%) were cemented and 212 (64%) were cement-
less THA. Preoperative diagnoses were primary osteoar-
thritis in 252 hips (76%), osteonecrosis in 32 (10%),
posttraumatic arthritis in 24 (7%), developmental dyspla-
sia of the hip in 14 (4%), rheumatoid arthritis in 6 (2%),
and residual arthritis from slipped capital femoral epi-
physis in two hips (1%). The mean age at follow-up of
eighty patients who received bilateral THA was older
compared to subjects with unilateral THA (73 vs 69.7
years; p = 0.039), but no sex differences were found
between these two groups. Out of 250 participants, 189
(76%) agreed to return for a follow-up visit, and 61
(24%) answered our questionnaires through a telephone
interview. The mean ± standard deviation (SD) length of
follow-up for the participants was 16.1 ± 3.6 years
(range 11-23). During the follow-up visits, the patients
gave their informed consent and underwent a complete
physical examination as well as weight and height mea-
surement. The clinical investigation was carried out by
one of the authors, who was not involved in the primary
care. The following patient-oriented instruments were
chosen to evaluate the patients: the Italian version of
the Short Form-36 Health Survey (SF-36) Questionnaire
[10], the Harris Hip Score (HHS) [11], the Italian ver-
sion of the Western Ontario and Mac Master University
(WOMAC) Questionnaire [12], the Functional
Comorbidity Index (FCI) [13], and a study-specific
questionnaire dealing with patients’ daily life activities,
medical history, intensity and frequency of hip pain,
possible reoperations, degree of satisfaction with sur-
gery, and willingness to undergo the same operation
a g a i n .T h eS F - 3 6Q u e s t i o n n a i r ei sag e n e r i cm e a s u r e
of health status which contains 36 questions measuring
the physical, social, and mental components of sub-
jects. It yields an eight-scale profile of scores (i.e. phy-
sical functioning = PF; role physical = RP; bodily pain
= BP; general health = GH; vitality = VT; social func-
tioning = SF; role emotional = RE; mental health =
MH) as well as summary physical (PCS) and mental
(MCS) measures. SF-36 results were compared to the
published data [14]. The HHS is a widely used disease-
specific outcome measure for THA studies to assess
pain and functional status. Sum scores are fitted in a
0-100 scale, with high values indicating less pain or
better physical functioning. The WOMAC is a self-
administered disease-specific validated outcome mea-
sure that evaluates pain (5 items), stiffness (2 items),
and physical function (17 items). A total WOMAC
summary score is calculated for each individual,
adjusted, and reported on a 0-to-100 scale. Lower
scores are associated with less pain and stiffness and
better function. The FCI is a validated 18-item list of
diagnoses designed to assess the burden of comorbid-
ities on physical function. Each item is given 1 point if
present, and the final score is the sum of the items.
Fifteen randomly selected study subjects completed the
questionnaires twice (the second time after a 20-day
interval) to assess test-retest reliability. Pearson’sp r o -
duct-moment correlation coefficients for the results of
the tests ranged from 0.71 to 0.90 for the SF-36 scale
scores, and averaged 0.84 and 0.86 for the HHS and
WOMAC, respectively, and 0.90 for the FCI. The same
Figure 1 Flow chart explaining the selection of patients.
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interviewed by telephone. In these patients, since range
of motion and deformity cannot be assessed by tele-
phone, a modified HHS with a correction factor was
adopted [15]. Since our study was carried out on surgi-
cally treated patients only without any control group
including untreated patients, we compared our results
with those obtained by other authors in patients
affected by advanced hip osteoarthritis.
Statistical analysis
At w o - s a m p l et t e s t ,A N O V A ,a n dc h i - s q u a r et e s tw e r e
used to test the significance of the cross-sectional differ-
ences between groups. A Bonferroni test was used to
test the differences between multiple groups. Pearson’s
correlation coefficient was used to assess the relation-
ships among patient-oriented outcomes. Models of mul-
tiple stepwise linear and logistic regression analysis were
constructed to evaluate the relationships between the
Table 1 Characteristics of the patients (n = 250)
Patients data Mean ± SD (range) or N (%)
Age at the present follow-up 70.8 ± 11.8 (35-88)
Age at the operation 55.3 ± 11.7 (21-70)
Sex
Female 162 (64.8%)
Male 88 (35.2%)
Body mass index 27.02 ± 4.3 (19-47.8)
Educational level
Illiteracy 17 (6.8%)
Primary School 87 (34.8%)
Secondary School 78 (31.2%)
High School 55 (22%)
Graduation 13 (5.2%)
Cigarette smoking
Non-smokers 178 (71.2%)
Ex-smokers 36 (14.4%)
Regular smokers 36 (14.4%)
Leisure activities
None 232 (92.8%)
Sport 14 (5.6%)
Hobby 18 (7.2%)
Preoperative employment
Employed 108 (43.2%)
Retired 32 (12.6%)
Housewife 110 (44.1%)
Change of job/workload after operation
Yes 45 (18%)
No 205 (82%)
Change in strain at work after operation (subjects with change of postoperative employment)
More sedentary 35 (77.8%)
Not different 10 (22.2%)
Functional Comorbidity Index 3.6 ± 1.9 (0-8)
0 14 (5.6%)
1 26 (10.4%)
2 28 (11.2%)
3 54 (21.6%)
4 50 (20%)
5 34 (13.6%)
6 24 (9.6%)
7 14 (5.6%)
8 6 (2.4%)
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and categorical distributions, respectively. Summary
measures and single scale scores of the SF-36, as well as
the WOMAC scores and the HHS, were treated as con-
tinuous outcome variables. Satisfaction with surgery,
willingness to undergo the operation again, and occur-
rence of reoperation were categorical outcomes. Expla-
natory variables included in the analysis were: present
age (continuous), gender (categorical), age at operation
(continuous), bilaterality of the procedure (categorical),
length of follow-up (continuous), BMI (continuous),
educational level (discrete), FCI (discrete), cigarette
smoking (categorical), sport practise (categorical), post-
operative employment (i.e. keeping preoperative job/
workload - categorical), cemented THA (categorical),
and possible reoperations (categorical). The patients’
educational level was graded as follows: 1) illiterate, 2)
primary school, 3) secondary school, 4) high school, and
5) graduation. Before constructing the models, age-
adjusted univariate linear and logistic regression analyses
were performed. Explanatory variables were included in
our multiple regression models if a trend toward an
association (i.e. p ≤ 0.10) with the outcome of interest
was found in the univariate analysis. In the multiple lin-
ear regression analysis, total R
2 for the model and
changes in R
2 for the independent contribution of single
factors were calculated to assess the percent of total var-
iance in the outcome accounted for by the whole model
and by single explanatory variables, respectively. In mul-
tiple logistic regression, log-likelihood tests were
obtained to evaluate the independent contribution of
single explanatory variables in the fit of the model. A p-
value of less than 0.05 was considered significant. SPSS
software program (SPSS, Inc., Chicago, IL, USA) was
used for the database and statistics.
Results
General health
The subjects’ SF-36 scores, stratified into three age
groups, are reported in Table 2 in comparison with the
age-matched normative data [14]. The SF-36 physical
indexes of patients compared negatively with the norma-
tive values, mainly in the two youngest age groups. Sig-
nificantly lower values were observed in the older age
groups compared with the youngest age group. Patients
with unilateral THA scored better than patients with
bilateral THA on the RP (p < 0.001), GH (p < 0.05), SF
(p < 0.05), and PCS (p < 0.05) SF-36 scales. The only
difference between patients with different preoperative
diagnoses were that better results were obtained by sub-
jects with osteonecrosis compared to those with OA on
the PCS (p = 0.022) scale. No significant differences
were found between patients who received cementless
or cemented THA, or who had undergone revision pro-
cedures or not during the follow-up period.
Disease-specific quality of life
Mean HHS and WOMAC questionnaire results are
reported in Table 3, stratified into three age groups in com-
parison with age-matched normative data when available
[16]. Subjects from the study group obtained poorer scores
in comparison with the values of healthy subjects, and the
Table 2 SF-36 scores (mean ± SD) in patients (PTS) and age-matched population norms (CTR)[14]
AGE GROUPS (years)
≤ 64 65-74 ≥ 75
SF-36 scale PTS (n = 50) CTR* PTS (n = 82) CTR PTS (n = 118) CTR
PF 58.4 ± 30
b,c 87.5 44.1 ± 26 71.7 ± 24 37.4 ± 30 50.2 ± 33
RP 62.0 ± 37 79.7 50.0 ± 42 65.9 ± 38 54.7 ± 43 52.6 ± 50
BP 60.5 ± 26
a,d 77.6 48.5 ± 20 67.6 ± 26 45.2 ± 19 53.3 ± 35
GH 50.6 ± 13
a,d 65.0 41.2 ± 16 55.4 ± 19 35.9 ± 16 43.1 ± 25
VT 54.3 ± 13
b 65.5 49.1 ± 16 59.3 ± 19 45.4 ± 17 46.7 ± 25
SF 66.0 ± 24
b 79.4 57.6 ± 22 75.8 ± 23 52.7 ± 24 63.4 ± 30
RE 77.3 ± 35 77.0 65.3 ± 42 73.5 ± 34 67.4 ± 39 57.1 ± 48
MH 57.2 ± 10 70.1 54.5 ± 13 64.7 ± 19 55.9 ± 10 58.5 ± 25
PCS 40.9 ± 10
a,d 49.5 35.3 ± 10 42.7 ± 9 32.5 ± 11 35.8 ± 11
MCS 45.0 ± 7 46.3 44.8 ± 9 45.8 ± 9 45.3 ± 7 41.4 ± 11
PF = Physical Functioning; RP = Role-Physical; BP = Bodily Pain; GH = General Health; VT = Vitality; SF = Social Functioning; RE = Role-Emotional; MH = Mental
Health
*mean between 45-54 and 55-64 age decade norms
aP≤ 0.001 vs. age group ≥ 75 years
bP≤ 0.01 vs. age group ≥ 75 years
cP≤ 0.05 vs. age group 65-74 years
dP≤ 0.01 vs. age group 65-74 years
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Patients aged 75 years or more had worst results when
compared to the two younger age groups. No significant
differences in HHS and WOMAC results emerged between
patients operated on by different surgeons, with different
diagnosis, with uni- or bilateral THA, or who underwent
revision arthroplasty or not. The hip functionality was
worse in subjects who changed their employment in the
postoperative period, compared to those who did not
(WOMAC score: p = 0.001; HHS: p < 0.01).
Post-surgical satisfaction and revision rate
Of the 250 responders, 240 (96%) were satisfied with the
outcome of their surgery and 242 subjects (96.8%) said
that they would undergo the same procedure again. No
difference in these outcomes was noted when patients
operated on by different surgeons were compared. A
preoperative diagnosis of hip dysplasia was associated
w i t hal e s s e rd e g r e eo fp o s t o perative satisfaction and
willingness to undergo the surgery again. Indeed, the
satisfaction rate was 97.5% and 66.6% in patients with
such a diagnosis or not, respectively (p = 0.001). One-
hundred eighty-two patients (72.8%) had experienced
pain in their operated hip over time, which was referred
to as mild and sporadic in 160 cases (87.9%) and moder-
ate or continuous in 22 cases (12.1%). The intensity of
pain on the 10-step visual analogic scale averaged 2.8 ±
2 (range 1-8). The pain appeared at exertion and/or in
standing position in 174 (95.6%) and 78 (42.9%) patients,
respectively. Seventy-two patients (28.8%) reported cur-
rent consumption of pain alleviating medications. Forty-
one THA in 36 patients were revised, leading to a reo-
peration rate of 12.4%. Five patients underwent a bilat-
eral revision procedure. No difference in the reoperation
rate was noted between the different operating surgeons
or the preoperative diagnoses.
Correlation and regression analysis
There were significant correlations between HHS and
PCS (c = 0.69; p < 0.001), PCS and the WOMAC score
(c = -0.71; p < 0.001), and HHS and the WOMAC score
(c = -0.88; p < 0.001). A weaker but still significant cor-
relation was noted between these three physical indexes
and the MCS. Major determinants (i.e. those explaining
a variation in the variance of the outcome of the model
≥ 3%) of the SF-36 summary and scale scores are
reported in Table 4. The hip functionality assessed by
either the WOMAC score or HHS (only the best predic-
tor is reported in the table) was closely related to both
physical and mental HRQoL. In our models, the varia-
tion in these indexes of hip functionality explained
about half of the percent variance of PCS and PF scale
scores. Comorbidities as assessed by FCI were another
significant but less important determinant. A higher
level of education showed a trend toward a positive
association (p = 0.07) with some physical indexes on the
SF-36 questionnaire (PCS, PF, and BP). Hip functionality
(WOMAC score and HHS) (Table 5) was positively
associated with the postoperative resumption of preo-
perative employment and negatively associated with age
and with the number of comorbidities. The older the
age at operation, the better the long-term WOMAC
score, although this explanatory variable accounted for
only a small amount of the variation in this disease-spe-
cific index. During our multivariate analysis, neither the
bilaterality of the procedure, use of cemented or
cementless implant, nor possible reoperations was found
to be related to the WOMAC scores and HHS. The
functionality of the operated hip (WOMAC score and
HHS) was a major positive determinant of long-term
satisfaction with the surgery and willingness to undergo
the surgery again, whereas the number of comorbidities
was negatively related to these outcomes. Results of the
models including this outcome and its best functional
predictor (the WOMAC score) are shown in Table 6. If
the scores of the domains of the WOMAC scale were
used separately as single determinants of postoperative
satisfaction and willingness to undergo the surgery
again, then the most relevant predictor was the pain
scale score. Several factors were found to be associated
Table 3 HHS and WOMAC scores (mean ± SD) in patients (PTS) and age-matched population norms (CTR)[16]
Age ≤ 64 Age 65 - 74 Age ≥ 75 All subjects
PTS
(N = 50)
PTS
(N = 82)
CTR PTS
(N = 118)
CTR PTS
(N = 250)
CTR
Total WOMAC 19.4 ± 20
a 26.4 ± 17
b 3.1 ± 6 34.5 ± 20 2.4 ± 3.8 28.8 ± 20 3.1 ± 7
Function 16.0 ± 16
a 22.2 ± 14
c 1.9 ± 4 28.1 ± 16 1.2 ± 2 23.6 ± 16 1.8 ± 5
Stiffness 1.1 ± 2 1.0 ± 2 0.3 ± 7 1.5 ± 2 0.4 ± 1 1.2 ± 2 0.4 ± 1
Pain 2.3 ± 4
a 3.2 ± 3
b 0.6 ± 1 4.9 ± 4 0.7 ± 1 3.8 ± 4 0.8 ± 2
Harris Hip Score 81.6 ± 17
a 75.5 ± 14
c 94.1 ± 10 68.8 ± 18 93.7 ± 7 74.8 ± 17 94 ± 82
aP≤ 0.001 vs. age group ≥ 75 years
bP≤ 0.01 vs. age group ≥ 75 years
cP≤ 0.05 vs. age group ≥ 75 years
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lysis (Table 6), but they had lesser importance as out-
come predictors.
Discussion
The main result of the present study is that patients
who had undergone THA a mean of 16 years earlier
had poorer long-term HRQoL with respect to age-
matched healthy controls [14]. However, their scores on
physical SF-36 scales were higher in comparison with
those previously reported in subjects with advanced hip
osteoarthritis (Table 7) [1,17-20]. In the present study
the older the age group, the lower the SF-36 scale scores
and summary measures. To the best of our knowledge,
no previous studies that used this validated instrument
with a comparably long follow-up period have been
published. Thus, making exact comparisons with our
findings is impossible. Several prospective studies deal-
ing with early results of THA have shown that patients
may obtain normal age- and sex-adjusted SF-36 values
3-12 months after surgery [2,3,21], but twelve to 36
months after THA, SF-36 parameters start to decrease
over time [20,22,23]. In the long term, Rat et al. [23]
reported SF-36 scores similar to ours 10 years after
Table 4 Determinants of SF-36 scores; multiple linear regression analysis
Outcome
Explanatory variable c 95% CI P Total adjusted R
2 %* R
2 Change %**
PCS
WOMAC score -0.28 -0.32 – -0.22 < 0.001 64 49
FCI score -1.83 -0.23 – -1.35 < 0.001 12
MCS
HHS 0.16 0.11 – 0.21 < 0.001 15 14
PF
WOMAC score -0.92 -1.06 – -0.79 < 0.001 60 54
FCI score -3.53 -4.81 – -2.25 < 0.001 5
RP
HHS 0.86 0.59 – 1.14 < 0.001 24 16
Bilateral THA -19,79 -29.72 – -9.85 < 0.001 4
BP
HHS 0.60 0.49 – 0.71 < 0.001 47 38
FCI score -3.51 -4.60 – -2.43 < 0.001 9
GH
HHS 0.38 0.30 – 0.46 < 0.001 37
FCI score -2.76 -3.56 – -1.96 < 0.001 54 13
Follow-up length -0.06 -0.09 – -0.02 0.001 3
VT
WOMAC score -0.30 -0.38 – -0.21 < 0.001 34
FCI score -2.87 -3.62 – -2.12 < 0.001 50 13
Postoperative employment 5.52 2.07 – 8.98 0.002 3
SF
HHS 0.65 0.53 – 0.76 < 0.001 48 41
FCI score -3.24 -4.34 – -2.14 < 0.001 7
RE
HHS 0.97 0.73 – 1.21 < 0.001 21 21
MH
HHS 0.27 0.20 – 0.34 < 0.001 29 23
FCI score -1.50 -2.19 – -0.81 < 0.001 4
C = coefficient; CI = confidence interval; SF-36 = Short Form-36 Health Survey; PCS = physical component summary; MCS = mental component summary; PF =
physical functioning; RP = role physical; BP = bodily pain; GH = general health; VT = vitality; SF = social functioning; RE = role emotional; MH = mental health;
FCI = Functional Comorbidity Index
* = total adjusted R2 accounted for by the whole model
** = only explanatory variables accounting for a R2 variation in the outcome ≥ 3 are reported
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physical and mental scales of SF-36 were lower than
those for a general population with comparable age.
Another long-term study [24] used a different validated
questionnaire (i.e. the Nottingham Health Profile) that
measures patient evaluation of the functional, social,
and emotional impact of chronic disease. This study
showed impaired quality of life in patients who had
undergone THA 15 years earlier. These patients fared
worse than the control group in most areas of perceived
health. Moreover, they considered daily function to be
affected negatively by health problems as compared with
the control subjects. In our patients, also the indexes of
hip functionality (the WOMAC questionnaire and HHS)
compared negatively with those of healthy controls [16]
but positively with those of patients with hip osteoar-
thritis [1]. Moreover, these scores were equal to or bet-
ter than the findings of other THA studies with earlier
follow-up data [22,25,26]. In our multivariate analyses,
t h eW O M A Cs c o r ea n dH H Sw e r ee s s e n t i a ld e t e r m i -
nants of SF-36’ PCS and PF scale scores, showing that
hip functionality is critical in determining the patient’s
general functioning. In these models, comorbidities were
negatively correlated with SF-36, WOMAC, and HHS
results. This result is in keeping with previous studies
that used the SF-36 [1,6,23] and WOMAC and HHS
[1,21] questionnaires to evaluate either operated or non-
operated subjects. The frequency of subjects who kept
their preoperative employment after surgery was similar
to other studies [27,28]. Resuming preoperative job or
Table 5 Determinants of WOMAC scores and HHS; multiple linear regression analysis
Outcome
Explanatory variable c 95% CI P Total adjusted R
2 %* R
2 Change %**
HHS
Age -1.22 -1.77 – -0.68 < 0.001 15
Postoperative employment 12.70 8.24 – 17.16 < 0.001 35 11
FCI score - 1.85 -2.92 – -0.78 0.001 5
Total WOMAC
Postoperative employment -14.89 -19.51 – -10.27 < 0.001 13
FCI score 2.36 1.19 – 3.52 < 0.001 30 10
Age 1.20 0.66 – 1.75 < 0.001 4
Age at operation -0.90 -1.43 – -0.36 0.001 3
WOMAC function
FCI score 2.35 1.43 – 3.28 < 0.001 13
Postoperative employment -12.22 -15.90 – -8.53 < 0.001 32 13
Age 0.92 0.49 – 1.36 < 0.001 3
Age at operation -0.71 -1.14 —0.28 0.001 3
WOMAC stiffness
Postoperative employment -0.70 -1.18 – -0.22 0.004 5 3
WOMAC pain
Age 0.22 0.10 – 0.33 < 0.001 8
Postoperative employment -1.94 -2.90 – -0.97 < 0.001 19 6
Age at operation -0.14 -0.26 – -0.03 0.017 3
C = coefficient; CI = confidence interval; FCI = Functional Comorbidity Index
* = total adjusted R2 accounted for by the whole model
** = only explanatory variables accounting for a R2 variation in the outcome ≥ 3 are reported
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tionality, as assessed by the WOMAC and HHS ques-
tionnaires. This is in good agreement with the results of
Bohm [28], who found better Oxford-12 hip scores
among those returning to work after THA. As stated by
this author, a better hip functionality is likely to posi-
tively impact the ability to return to work, although this
relationship may not be causal (i.e. the ability to resume
work by itself may positively influence the patient’ss e l f
reported functionality).
Despite the impairment in the HRQoL, the level of
post-surgical satisfaction in our study group was high
and the 96% rate of satisfied patients is equal to or
superior to the percentages previously reported in stu-
dies with shorter follow-up intervals [22,25,29]. This dis-
crepancy between the rate of satisfied patients and
HRQoL is not surprising. Indeed, several different fac-
tors apart from hip functionality (i.e. patient expectation,
pain relief, psychological benefit, and improvement in
activities of daily life) can influence the level of post-sur-
gical satisfaction [30].
We acknowledge some methodological weaknesses in
the present study. Due to its observational and retro-
spective character, it lacks reliable baseline data and a
control group. However, performing a prospective analy-
sis with such a follow-up is very challenging. Thus, we
could have been subject to variability in information
gathering that might have existed at the time these
patients were treated. Nevertheless, the information
obtained from medical records and used in the present
analysis mostly consisted of unambiguous personal,
demographic, or occupational data. Moreover, the com-
prehensive assessment by validated patient-oriented
tools warranted comparisons with age and sex-matched
norms, thus mitigating the lack of a control population.
At the time the patients in our study group underwent
their surgery, many of the validated questionnaires used
in the present study were not available. This lack in
comparable baseline data prevented us from evaluating
the postoperative changes in these patients’ status. How-
ever, this study was only designed to evaluate the influ-
ence of a THA on the long-term HRQoL and hip
functionality of unselected patients. As stated in large
register-based studies [31], the effectiveness of a widely
used routine surgical technique (such as THA) can be
evaluated better in observational studies than in rando-
mised ones, because patients enrolled in these latter
Table 6 Determinants of patients’ satisfaction with
surgery and reoperation; multivariate logistic regression
analysis
Explanatory
variables
OR 95% CI P - 2 Loglikelihood
ratio (LR)
Satisfaction
WOMAC score 0.88 0.82-0.94 < 0.001 29.46
FCI score 0.37 0.16-0.86 0.021 9.95
Willingness to undergo the operation again
WOMAC score 0.83 0.73-0.95 0.007 23.59
FCI score 0.09 0.01-0.65 0.017 18.53
Age 1.12 1.00-1.24 0.041 5.01
Reoperation
Postoperative
employment
0.34 0.15-0.78 0.011 6.33
Follow-up length 1.01 1.00-1.02 0.023 5.38
Cemented THA 0.38 0.15-0.99 0.048 4.34
OR = odds ratio; CI = confidence interval; WOMAC = Western Ontario and
Mac Master University questionnaire; FCI = Functional Comorbidity Index; THA
= total hip arthroplasty
Table 7 SF-36 scores (mean ± SD) in the study group and in patients with advanced osteoarthritis
Author Present study Croft
[17]
Nilsdotter
[18]
Salaffi
[1]*
Ng
[19]
SooHoo
[20]
Patients n. 250 611 124 107 627 89
Mean age (years) 70.8 70.9 71 67.8 68 60
SF-36 scale PF 43.8 ± 30 28.9 31.5 ± 21 43.4 ± 23 23.1 ± 18 23
RP 54.6 ± 41 11.5 ± 24 24.8 ± 35 6.6 ± 16 24
BP 49.3 ± 22 31.2 ± 16 26.3 ± 21 27.4 ± 17 30
GH 40.6 ± 17 56.2 69.7 ± 19 44.8 ± 22 74.3 ± 20 66
VT 48.4 ± 17 60.4 48.7 ± 22 46.7 ± 20 43.9 ± 21 49
SF 57.0 ± 24 48.7 66.6 ± 26 58.9 ± 24 53.7 ± 30 58
RE 68.7 ± 39 40.0 ± 44 42.1 ± 32 45.2 ± 33 56
MH 55.7 ± 11 64.5 69.7 ± 20 57.4 ± 22 71.8 ± 19 67
PCS 35.1 ± 11 31.1 ± 8 31
MCS 45.3 ± 8 38.9 ± 9 50
PF = Physical Functioning; RP = Role-Physical; BP = Bodily Pain; GH = General Health; VT = Vitality; SF = Social Functioning; RE = Role-Emotional; MH = Mental
Health
*Patients not scheduled for THA with hip osteoarthritis of variable severity
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Page 8 of 10studies are frequently not representative of the entire
cohort of subjects undergoing THA in the routine clini-
cal practice, due to the stringent exclusion criteria.
Lastly, although multiple attempts were made to trace
all the patients for follow-up evaluation, this was impos-
sible due to the long elapsed time and the death of
many patients. Nevertheless, we obtained a satisfactory
survey rate of more than 80% of the surviving patients,
which is superior to other studies with shorter times
until follow-up [6]. Comparison of the included patients
with those lost to follow-up suggested that these partici-
pants were representative of the entire population. Main
strengths of our study are the use of validated instru-
ments and length of follow-up, since to the best of our
knowledge, no previous studies that used these validated
patient-oriented tools had similarly long intervals post-
surgery.
Conclusions
This paper demonstrates that patients who had under-
gone THA a mean of 16 years earlier have impaired
self-reported physical HRQoL and hip functionality, but
they still perform physically better than untreated
patients with hip osteoarthritis. The hip functionality is
a major determinant of physical HRQoL, but other rele-
vant factors, such as the number of comorbidities, can
also influence the ability of subjects. Despite the impair-
ment in the HRQoL, the level of post-surgical satisfac-
tion was high in this study group.
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